BackFidelity Select Biotechnology Portfolio Overview
Fidelity Select Biotechnology Portfolio

Fidelity Select Biotechnology Portfolio Return on Equity

Latest ROE for Fidelity Select Biotechnology Portfolio: -0.77% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

-0.77%

Return on Equity

-0.77%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Fidelity Select Biotechnology Portfolio (FBIOX) FAQ

As of the most recent data, FBIOX shows a ROE of -0.77%. That is above the sector sector average of -5.93%. Scroll down for historical charts and peer comparison views.

The its sector sector average ROE is about -5.93%. Fidelity Select Biotechnology Portfolio is at -0.77%, which is higher that average. That is roughly 87.1% above the sector mean. Use the comparison chart on this page to see how FBIOX stacks up against individual peers as well.

Check the historical chart to see whether FBIOX's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Fidelity Select Biotechnology Portfolio with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Fidelity Select Biotechnology Portfolio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently -0.77%) with ownership activity and broader fundamentals.